Single-Dose Amphetamines in ADHD

J Gordon Millichap

doi:10.15844/pedneurbriefs-15-11-1

Single-Dose Amphetamines in ADHD

Pediatric Neurology Briefs

Volume 15 (2001): Issue 11

By: J Gordon Millichap

Open Access

|Nov 2001

Abstract

The efficacy and time course of single morning doses of Adderall®, extended-release (Spansules), and immediate-release (tablets) dextroamphetamine sulfate (DXA) and placebo were compared in 35 children with attention-deficit/hyperactivity disorder (ADHD) in a randomized, double-blind, crossover study at the Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD.

References

James RS Sharp WS Bastain TM Lee PP Walter JM Czarnolewski M Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD J Am Acad Child Adolesc Psychiatry 2001 Nov 40 11 1268 1276 10.1097/00004583-200111000-00006 11699800
Open DOI Search in Google Scholar Back to article
Kramer AF Cepeda NJ Cepeda ML Methylphenidate effects on task-switching performance in attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 2001 Nov 40 11 1277 1284 10.1097/00004583-200111000-00007 11699801
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-15-11-1 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 81 - 82

Published on: Nov 1, 2001

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Attention-Deficit/Hyperactivity Disorder,

Methylphenidate,

High-Dose Adderall

© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 15 (2001): Issue 11